Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemisch Pharmazeutische Forschungsgesellschaft M.B.H.filedCriticalChemisch Pharmazeutische Forschungsgesellschaft M.B.H.
Priority to MD94-0244ApriorityCriticalpatent/MD940244A/en
Publication of MD940244ApublicationCriticalpatent/MD940244A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
The invention relates to the new therapeutically valuable tetrazole derivatives which may be applied for high blood pressure treatment caused by angiotensine II.The purpose of the invention consists in the creation of pure competitive antagonists which don't form competitive met.The subject matter of the invention are the new tetrazole derivatives of the formula:as well as pharmaceutical applicable salts thereof.It is described a process for obtaining said compounds. The new compounds individually or in mixture with other active substances in the form of simple galena compositions may be applied as drugs for high blood pressure treatment and other cardiovascular diseases.
MD94-0244A1994-07-121994-07-12New derivatives of tetrazole, process for obtaining thereof and pharmaceutical composition on base thereof
MD940244A
(en)